Brajpal Singh Tyagi*

Professor, Harsh ENT Hospital, RDC, Ghaziabad, India

*Corresponding Author: Brajpal Singh Tyagi, Professor, Harsh ENT Hospital, RDC, Ghaziabad, India.

Received: September 10, 2025; Published: December 22, 2025

Abstract

PRP is an autologous concentrate of platelets containing growth factors (PDGF, VEGF, TGF-β, IGF, etc.).
These factors promote tissue repair, angiogenesis, and neural regeneration.

References

1. Dr Brajpal Singh Tyagi. “Platelet Rich Plasma (PRP): A Revolutionary Treatment of Sensorineural Hearing Loss”. Acta Scientific Otolaryngology (ASOL)4 (2019).
2. Qiaojun Fang., et al. “Stem cells as potential therapeutics for hearing loss”. Frontiers in Neuroscience 17 (2023): 1259889.
3. Jingwu Sun., et al. “3-DB-OTO Gene Therapy for Inherited Deafness”. New England Journal of Medicine (2025).

Citation

Citation: Brajpal Singh Tyagi. “Structured Review of PRP, Stem Cell, and Gene Therapy in Sensorineural Hearing Loss (SNHL)".Acta Scientific Otolaryngology 8.1 (2026): 26-27.

Copyright

Copyright: © 2026 Brajpal Singh Tyagi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.